A  Life Science Angels

http://www.lifescienceangels.com





     Office Locations:

1230 Bordeaux Drive
Sunnyvale, CA 94089
Phone: 408 -541-1152
Fax: 408-541-1418

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Life Science Angels (LSA) was founded in 2004 by senior life science executives and experienced Angel investors as a vehicle to bring Angel capital to worthy early-stage life sciences and healthcare companies. Formally launched in January 2005, with backing from 13 industry sponsors, LSA follows a rigorous due diligence process before presenting investment opportunities to its membership. Direct investments range from $250k to $750k, with syndicated financings ranging from $1.5 million to $6 million. The firm invests in companies near to LSA champion or co-investors. Since 2005, LSA has invested nearly $60 million in over 40 companies which have received an additional $1 billion in follow-on funding from VCs and strategics. LSA has funded 100 startups with 14 exits.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Allan May Chairman and Founder
    Brock Sigel Co-Chair
    Casey McGlynn Secretary
    George Taylor Director, Businesss Plan Analyst and Mentor
    James Larrick Co-Chair

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      04/22/2024


      Pelvital


      MN


      $2,320,000


      Seed+


      04/03/2024


      Neurava


      IN


      $2,000,000


      Series A


     

    Portfolio companies include:


      Astrocyte


      Carmenta Bioscience
        web link


      Chameleon


      Chimera


      Eumentis


      Mission Bio


      Moleculo


      Neurava
        web link


      Pelvital
        web link


      Zephyrus’s Milo


     

    Recent News: